Last reviewed · How we verify
NCT07477938: Pep-SMARTID
A Single-Arm Interventional Trial of Pepper- Robot Delivered Cancer Education for Adults With Intellectual Disability
NA trial testing Robot delivered Education in Cancer Awareness and Prevention Education in 25 participants. Not yet recruiting.
30 July 2026
Quick facts
| Lead sponsor | National University of Ireland, Galway, Ireland |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 25 |
| Start date | 1 May 2026 |
| Primary completion | 30 July 2026 |
| Estimated completion | 30 September 2026 |
| Sites | 1 location across Ireland |
Drugs / interventions tested
- Robot delivered Education
Conditions studied
- Cancer Awareness and Prevention Education — all drugs for Cancer Awareness and Prevention Education →
- Breast Cancer Awareness — all drugs for Breast Cancer Awareness →
- Intellectual Disabilities (F70-F79) — all drugs for Intellectual Disabilities (F70-F79) →
Sponsor
National University of Ireland, Galway, Ireland
Who can join
18 and older, any sex, with Cancer Awareness and Prevention Education or Breast Cancer Awareness. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Individuals with Intellectual disability face numerous barriers to cancer education, awareness and screening, including communication challenges, anxiety, and a lack of accessible educational resources. Traditional methods often fail to meet their unique learning needs, contributing to lower screening rates , delayed diagnoses and poorer outcomes.. Socially assistive robots, have demonstrated effectiveness in delivering interactive, engaging, and tailored education, helping individuals with cognitive impairments better understand medical procedures and the importance of preventive care. The study investigators propose to conduct a pilot single arm clinical trial with a semi humanoid robot to deliver cancer awareness education to adults with intellectual disability attending a disability day service in Ireland .The semi humanoid robot will be programmed to engage in 2 way communication about the cancer related educational content that is uploaded on its system. .Approximately 25 adults with ID will receive the robot led educational intervention addressing both breast and colorectal cancer awareness and screening. This a pragmatic pilot study to inform a future larger controlled clinical trial Our overall objective is to Improve breast and colorectal cancer awareness knowledge level among adults with ID receiving a robot-delivered education intervention
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07477938
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cancer Awareness and Prevention Education
Currently open trials in the same condition.
- NCT05761782 — Engaging Diverse and Underserved Communities in Cancer Awareness Training and Education · recruiting
Other National University of Ireland, Galway, Ireland trials
Trials by the same sponsor.
- NCT06147479 — Cognitive Stimulation in Daily Activities for People Living With Early to Middle Stage Dementia · NA · completed
- NCT06212050 — Feasibility, Safety, and Effectiveness of the ACURATE neo2 Transcatheter Heart Valve for Severe Bicuspid Aortic Stenosis · enrolling by invitation
- NCT05170100 — Evaluating a Digital Intervention for Overactive Bladder · NA · completed
- NCT04471103 — Comparison of Multi-Round and Real-Time Delphi Survey Methods · NA · unknown
- NCT05130697 — A Multicenter Survey Study Into Patient Experience With Mobile Apps · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07477938 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National University of Ireland, Galway, Ireland
- Last refreshed: 17 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07477938.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing